Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).Bioorg Med Chem Lett. 2009 Aug 01; 19(15):4050-4.BM
Abstract
Based on screening hit 1, a series of tricyclic quinoxalinones have been designed and evaluated for inhibition of PARP-1. Substitutions at the 7- and 8-positions of the quinoxalinone ring led to a number of compounds with good enzymatic and cellular potency. The tricyclic quinoxalinone class is sensitive to modifications of both the amine substituent and the tricyclic core. The synthesis and structure-activity relationship studies are presented.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
19553114
Citation
Miyashiro, Julie, et al. "Synthesis and SAR of Novel Tricyclic Quinoxalinone Inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)." Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 15, 2009, pp. 4050-4.
Miyashiro J, Woods KW, Park CH, et al. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg Med Chem Lett. 2009;19(15):4050-4.
Miyashiro, J., Woods, K. W., Park, C. H., Liu, X., Shi, Y., Johnson, E. F., Bouska, J. J., Olson, A. M., Luo, Y., Fry, E. H., Giranda, V. L., & Penning, T. D. (2009). Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters, 19(15), 4050-4. https://doi.org/10.1016/j.bmcl.2009.06.016
Miyashiro J, et al. Synthesis and SAR of Novel Tricyclic Quinoxalinone Inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg Med Chem Lett. 2009 Aug 1;19(15):4050-4. PubMed PMID: 19553114.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
AU - Miyashiro,Julie,
AU - Woods,Keith W,
AU - Park,Chang H,
AU - Liu,Xuesong,
AU - Shi,Yan,
AU - Johnson,Eric F,
AU - Bouska,Jennifer J,
AU - Olson,Amanda M,
AU - Luo,Yan,
AU - Fry,Elizabeth H,
AU - Giranda,Vincent L,
AU - Penning,Thomas D,
Y1 - 2009/06/13/
PY - 2009/04/21/received
PY - 2009/06/03/revised
PY - 2009/06/05/accepted
PY - 2009/6/26/entrez
PY - 2009/6/26/pubmed
PY - 2009/12/16/medline
SP - 4050
EP - 4
JF - Bioorganic & medicinal chemistry letters
JO - Bioorg Med Chem Lett
VL - 19
IS - 15
N2 - Based on screening hit 1, a series of tricyclic quinoxalinones have been designed and evaluated for inhibition of PARP-1. Substitutions at the 7- and 8-positions of the quinoxalinone ring led to a number of compounds with good enzymatic and cellular potency. The tricyclic quinoxalinone class is sensitive to modifications of both the amine substituent and the tricyclic core. The synthesis and structure-activity relationship studies are presented.
SN - 1464-3405
UR - https://www.unboundmedicine.com/medline/citation/19553114/Synthesis_and_SAR_of_novel_tricyclic_quinoxalinone_inhibitors_of_poly_ADP_ribose_polymerase_1__PARP_1__
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0960-894X(09)00848-8
DB - PRIME
DP - Unbound Medicine
ER -